Shareholders' Equity

9 Months Ended

Mar. 31, 2025

Stockholders' Equity Note [Abstract]

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY

Accumulated Other Comprehensive Loss

Changes in the accumulated other comprehensive loss are comprised of the following amounts, shown net of taxes:

	Three Months Ended March 31, 2025
	Foreign currency translation adjustment		Post-employment benefits		Cash flow hedge		Total Accumulated other comprehensive loss
Balance at December 31, 2024	$	(116,461)	$	(399)	$	11,026	$	(105,834)
Other comprehensive income	1,818		—		16		1,834
Amounts reclassified from accumulated other comprehensive loss	—		(3)		(2,759)		(2,762)
Net current-period other comprehensive income (loss)	1,818		(3)		(2,743)		(928)
Balance at March 31, 2025	$	(114,643)	$	(402)	$	8,283	$	(106,762)

	Three Months Ended March 31, 2024
	Foreign currency translation adjustment		Post-employment benefits		Cash flow hedge		Total Accumulated other comprehensive loss
Balance at December 31, 2023	$	(79,667)	$	(244)	$	20,265	$	(59,646)
Other comprehensive (loss) income	(5,147)		—		3,856		(1,291)
Amounts reclassified from accumulated other comprehensive loss	—		(24)		(3,528)		(3,552)
Net current-period other comprehensive (loss) income	(5,147)		(24)		328		(4,843)
Balance at March 31, 2024	$	(84,814)	$	(268)	$	20,593	$	(64,489)

	Nine Months Ended March 31, 2025
	Foreign currency translation adjustment		Post-employment benefits		Cash flow hedge		Total Accumulated other comprehensive loss
Balance at June 30, 2024	$	(95,566)	$	(391)	$	18,391	$	(77,566)
Other comprehensive loss	(19,077)		—		(718)		(19,795)
Amounts reclassified from accumulated other comprehensive loss	—		(11)		(9,390)		(9,401)
Net current-period other comprehensive loss	(19,077)		(11)		(10,108)		(29,196)
Balance at March 31, 2025	$	(114,643)	$	(402)	$	8,283	$	(106,762)

	Nine Months Ended March 31, 2024
	Foreign currency translation adjustment		Post-employment benefits		Cash flow hedge		Total Accumulated other comprehensive loss
Balance at June 30, 2023	$	(83,099)	$	(197)	$	28,000	$	(55,296)
Other comprehensive (loss) income	(1,715)		—		3,189		1,474
Amounts reclassified from accumulated other comprehensive loss	—		(71)		(10,596)		(10,667)
Net current-period other comprehensive loss	(1,715)		(71)		(7,407)		(9,193)
Balance at March 31, 2024	$	(84,814)	$	(268)	$	20,593	$	(64,489)

Other Comprehensive (Loss) Income

Details of other comprehensive (loss) income are as follows:

	Three Months Ended March 31,
	2025						2024
	Pre-Tax Amount		Tax (Benefit) Expense		Net Amount		Pre-Tax Amount		Tax Expense (Benefit)		Net Amount
Foreign currency translation adjustments	$	1,814	$	(4)	$	1,818	$	(5,112)	$	35	$	(5,147)
Post-employment benefits:
Reclassification of net actuarial gains and prior service cost into other expense (income), net and included in net periodic pension costs	(6)		(3)		(3)		(30)		(6)		(24)
Unrealized gain on cash flow hedge	21		5		16		5,105		1,249		3,856
Reclassification of interest from cash flow hedge into interest expense (income), net	(3,654)		(895)		(2,759)		(4,671)		(1,143)		(3,528)
Other comprehensive loss	$	(1,825)	$	(897)	$	(928)	$	(4,708)	$	135	$	(4,843)

	Nine Months Ended March 31,
	2025						2024
	Pre-Tax Amount		Tax Expense (Benefit)		Net Amount		Pre-Tax Amount		Tax Expense (Benefit)		Net Amount
Foreign currency translation adjustments	$	(19,046)	$	31	$	(19,077)	$	(1,685)	$	30	$	(1,715)
Post-employment benefits:
Reclassification of net actuarial gains and prior service cost into other expense (income), net and included in net periodic pension costs	(19)		(8)		(11)		(90)		(19)		(71)
Unrealized (loss) gain on cash flow hedge	(950)		(232)		(718)		4,203		1,014		3,189
Reclassification of interest from cash flow hedge into interest expense (income), net	(12,436)		(3,046)		(9,390)		(14,024)		(3,428)		(10,596)
Other comprehensive loss	$	(32,451)	$	(3,255)	$	(29,196)	$	(11,596)	$	(2,403)	$	(9,193)

Anti-dilutive Common Stock Equivalents

In the three months ended March 31, 2025 and 2024, stock options and stock appreciation rights related to 68 and 77 shares of common stock, respectively, were not included in the computation of diluted earnings per share for the period then ended as they were anti-dilutive. In the nine months ended March 31, 2025 and 2024, stock options and stock appreciation rights related to 88 and 102 shares of common stock, respectively, were not included in the computation of diluted earnings per share for the period then ended as they were anti-dilutive.